A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT ID: NCT00002362
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE3
INTERVENTIONAL
1999-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abacavir sulfate
Efavirenz
Emtricitabine
Stavudine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are HIV-positive and generally healthy.
* Have a viral load of 5,000 copies/ml or more.
* Have CD4 cell counts of 200 cells/mm3 or more.
* Are age 18 or older.
* Agree to practice sexual abstinence or use effective barrier methods of birth control (such as condoms).
Exclusion Criteria
* Have ever taken anti-HIV drugs for 3 days or more.
* Have had certain AIDS-related infections.
* Have had severe diarrhea within the past 30 days.
* Are unable to eat at least 1 meal a day due to nausea, vomiting, or stomach pain.
* Are being treated for active tuberculosis (TB).
* Are pregnant or breast-feeding.
* Use illegal drugs or alcohol that make it difficult for you to take study drugs or keep clinic appointments.
* Are taking certain medications, or have certain other conditions or diseases (see the technical summary for more detail).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Triangle Pharmaceuticals
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univ of Texas Health Sciences Ctr
San Antonio, Texas, United States
Ctr for AIDS Research / Education and Service (CARES)
Sacramento, California, United States
San Francisco Veterans Administration Med Ctr
San Francisco, California, United States
Gary Richmond MD
Fort Lauderdale, Florida, United States
Northstar Med Clinic
Chicago, Illinois, United States
South Jersey Infectious Diseases Inc
Somers Point, New Jersey, United States
North Shore Univ Hosp / Div of Infectious Diseases
Manhasset, New York, United States
Univ of Texas Southwestern Med Ctr of Dallas
Dallas, Texas, United States
Houston Clinical Research Network
Houston, Texas, United States
Univ of Texas / Med School at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FTC-301
Identifier Type: -
Identifier Source: secondary_id
298B
Identifier Type: -
Identifier Source: org_study_id